Xanthine Derivatives has 10 known drug interactions based on U.S. FDA drug labeling data. Notable interactions include combinations with Aclidinium Bromide And Formoterol Fumarate, Formoterol Fumarate, Formoterol Fumarate Dihydrate. Patients taking Xanthine Derivatives should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 10
- Moderate
- 10
Moderate (10)
- Xanthine Derivatives + Aclidinium Bromide And Formoterol Fumarate— Concomitant treatment may potentiate hypokalemic effect of beta-adrenergic agonist formoterol. Use with caution.
- Xanthine Derivatives + Formoterol Fumarate— May potentiate hypokalemic effect of formoterol. Use with caution.
- Xanthine Derivatives + Formoterol Fumarate Dihydrate— May potentiate hypokalemic effect of formoterol. Use with caution.
- Xanthine Derivatives + Glycopyrrolate And Formoterol Fumarate— Concomitant use may potentiate hypokalemic effect of formoterol. Use with caution.
- Xanthine Derivatives + Lithium— Can lower serum lithium concentrations by increasing urinary lithium excretion.
- Xanthine Derivatives + Lithium Carbonate— Concomitant use can lower serum lithium concentrations by increasing urinary lithium excretion. Frequent monitoring and …
- Xanthine Derivatives + Lithium Citrate— Can lower serum lithium concentrations by increasing urinary lithium excretion. Recommend frequent monitoring and dosage…
- Xanthine Derivatives + Mometasone Furoate And Formoterol Fumarate Dihydrate— May potentiate hypokalemic effect of formoterol. Use with caution.
- Xanthine Derivatives + Olodaterol Respimat Inhalation Spray— May potentiate hypokalemic effect of olodaterol. Use with caution.
- Xanthine Derivatives + Tiotropium Bromide And Olodaterol— Xanthine derivatives may potentiate hypokalemia or ECG changes when used with olodaterol. Use with caution.